Hydroxychloroquine Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Hydroxychloroquine Drugs Market is Segmented By Disease Type (Rheumatoid arthritis, Coronavirus Disease (COVID-19), Malaria, Lupus Erythematosus), Distribution Channel and Geography.

Hydroxychloroquine Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Hydroxychloroquine Drugs Market Size

Hydroxychloroquine Drugs Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
CAGR 16.80 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Hydroxychloroquine Drugs Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Hydroxychloroquine Drugs Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Hydroxychloroquine Drugs Market Analysis

The Hydroxychloroquine Drugs Market is expected to register a CAGR of 16.8% during the forecast period.

Recently, hydroxychloroquine has attracted attention due to its effectiveness in treating patients with coronavirus disease (COVID 19). Reports from China demonstrated chloroquine could possibly inhibit SARS-CoV-2 in vitro. The drug showed high efficacy in treating the patients with coronavirus disease (COVID 19). Hydroxychloroquine is expected to be a promising potential treatment for the coronavirus disease (COVID 19). The US Food and Drug Administration (FDA) designated hydroxychloroquine for emergency use for treating coronavirus disease (COVID 19).

Increasing demand for novel hydroxychloroquine and rising penetration of generic drugs are estimated to provide a significant boost to the market. For instance, in March 2020, Novartis International AG started the shipping of 30 million doses of hydroxychloroquine tablets to the US Department of Health and Human Services (HHS) for controlled clinical studies to evaluate the effectiveness of hydroxychloroquine in people who have tested positive for coronavirus disease (COVID 19). In addition, increasing product approval is poised to have strong market penetration due to the presence of increased government funding.

Growing patient awareness regarding COVID-19 and the influx of new generics in the global arena are projected to accelerate the adoption of hydroxychloroquine drugs. As per the Johns Hopkins University, as of 15th April 2020, approximately 609,516 people suffered from COVID-19 in the US alone. Increasing awareness regarding disease remittance therapies, rising clinical trials to evaluate the effectiveness of hydroxychloroquine in the treatment of COVID-19 are estimated to promote revenue growth. However, poor healthcare accessibility in low-income countries may restrain the growth of the market.

Hydroxychloroquine Drugs Industry Overview

Manufacturers offering generic versions dominate the global hydroxychloroquine drugs market. Companies are focusing on building generic chemical entities and innovative molecules to consolidate their foothold. Some of the prominent market participants are DR. REDDY'S LABORATORIES LTD, Laurus Labs Limited, Lupin, Mylan NV, Novartis International AG, Sanofi SA, Sun Pharmaceutical Industries Ltd, Teva Pharmaceuticals USA Inc., and Zydus Pharmaceuticals.

The introduction of generic versions and the strong clinical pipeline is anticipated to increase competition in the market. For instance, in April 2020, Zydus Cadila and Ipca Labs have backward integrated HCQ making capability with the aim to increase production capacity by 5-6 times to 70 MT per month thereby, expanding the range of treatment options for the millions of patients living with target diseases.

Hydroxychloroquine Drugs Market Leaders

  1. Sanofi S.A

  2. Sun Pharmaceutical Industries Ltd.

  3. Mylan N.V

  4. Teva Pharmaceuticals USA, Inc

  5. Zydus Pharmaceuticals

  6. *Disclaimer: Major Players sorted in no particular order
Hydroxychloroquine Drugs Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Hydroxychloroquine Drugs Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Disease Outbreaks Such As Coronavirus Disease (COVID 19)
    • 4.2.2 High prevalence of Malaria and Rheumatoid Arthritis
    • 4.2.3 Increasing Product Launches and Approvals
    • 4.2.4 Expanding Application of Hydroxychloroquine in Various Therapeutic Conditions
  • 4.3 Market Restraints
    • 4.3.1 Global Shortage of Hydroxychloroquine
    • 4.3.2 Poor Healthcare Accessibility in Low Income Countries
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 By Application
    • 5.1.1 Coronavirus Disease (COVID-19)
    • 5.1.2 Malaria
    • 5.1.3 Lupus Erythematosus
    • 5.1.4 Rheumatoid Arthritis
  • 5.2 By distribution Channel
    • 5.2.1 Online Pharmacy
    • 5.2.2 Hospital Pharmacy
    • 5.2.3 Retail Pharmacy
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 DR. REDDY'S LABORATORIES LTD
    • 6.1.2 Laurus Labs Limited,
    • 6.1.3 Lupin
    • 6.1.4 Mylan NV
    • 6.1.5 Novartis International AG
    • 6.1.6 Sanofi SA
    • 6.1.7 Sun Pharmaceutical Industries Ltd
    • 6.1.8 Teva Pharmaceuticals USA Inc.
    • 6.1.9 Zydus Pharmaceuticals
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Hydroxychloroquine Drugs Industry Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2025. For the purpose of this study, Mordor Intelligence has segmented the global hydroxychloroquine drugs market report on the basis of disease type, distribution channel, and region.

By Application Coronavirus Disease (COVID-19)
Malaria
Lupus Erythematosus
Rheumatoid Arthritis
By distribution Channel Online Pharmacy
Hospital Pharmacy
Retail Pharmacy
Geography North America United States
Canada
Mexico
Geography Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Geography Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Geography Middle-East and Africa GCC
South Africa
Rest of Middle-East and Africa
Geography South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Hydroxychloroquine Drugs Market Research FAQs

What is the current Hydroxychloroquine Drugs Market size?

The Hydroxychloroquine Drugs Market is projected to register a CAGR of 16.8% during the forecast period (2025-2030)

Who are the key players in Hydroxychloroquine Drugs Market?

Sanofi S.A, Sun Pharmaceutical Industries Ltd., Mylan N.V, Teva Pharmaceuticals USA, Inc and Zydus Pharmaceuticals are the major companies operating in the Hydroxychloroquine Drugs Market.

Which is the fastest growing region in Hydroxychloroquine Drugs Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Hydroxychloroquine Drugs Market?

In 2025, the North America accounts for the largest market share in Hydroxychloroquine Drugs Market.

What years does this Hydroxychloroquine Drugs Market cover?

The report covers the Hydroxychloroquine Drugs Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Hydroxychloroquine Drugs Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Hydroxychloroquine Drugs Industry Report

Statistics for the 2025 Hydroxychloroquine Drugs market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Hydroxychloroquine Drugs analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.